Guía para la atención integral de las personas con hipertensión arterial

Objectives

Provide a comprehensive, integrated national framework for preventing, detecting, diagnosing, treating, following up and rehabilitating people with hypertension in Ministry of Health and Social Security Fund services, with the overall aims of reducing hypertension-related morbidity, mortality and complications, improving quality of life, and harmonising care criteria.[1][2][3]

• Promote cardiovascular health and prevent hypertension through healthier diets, regular physical activity, weight management, stress reduction, avoidance of tobacco, harmful alcohol use and other drugs, and health education for patients, families and communities.[2][4][5]
• Detect hypertension early by measuring and recording blood pressure at medical consultations, targeting both the general population and people with relevant risk factors, including obesity, diabetes, unhealthy diet, sedentary behaviour, substance use and family history.[6][4]
• Assess cardiovascular risk, identify target-organ damage and secondary causes, and distinguish essential from secondary hypertension to support timely, risk-sensitive intervention.[7][8][9]
• Deliver individualised non-pharmacological and pharmacological management, considering blood-pressure level, cardiovascular risk, organ damage, co-morbidities, treatment response and patient characteristics.[10][11][12]
• Address priority populations and clinical circumstances, including pregnancy, older adults, people of Black ethnicity, people with diabetes or renal disease, and children and adolescents.[13][14][15]
• Provide rehabilitation and progressively specialised care for complications, including cerebrovascular sequelae, while supporting self-care, family involvement and social action for health.[3][16]
• Maintain an evidence-informed guideline through interdisciplinary review, validation, publication and updating every five years.[17][18]

Implementation

Implement the guideline through coordinated, multidisciplinary care across primary, secondary and tertiary services, combining health promotion, routine screening, structured clinical assessment, lifestyle counselling, medicines, follow-up, referral and information recording. Governance operates at local, regional and central levels, supported by the Adult Health Programme, health-facility teams and specialist services.[4][3][19][20]

• Base recommendations on systematic literature review, scientific evidence, consensus processes and clinical adaptation to the Panamanian context, with input from the Panamanian Society of Cardiology and international hypertension and cardiovascular organisations.[1]
• Coordinate implementation through regional Adult Health Programme coordinators, facility directors, multidisciplinary health teams and communities; use workshops, seminars and continuing education to address organisational barriers and strengthen staff capability.[1][4][19]
• Measure blood pressure using standardised procedures, functioning and calibrated equipment, appropriate cuffs, patient preparation and repeat readings where necessary; record readings in the clinical record.[21][22][6][23]
• Confirm adult hypertension through repeated measurements and assess patients using medical history, physical examination, cardiovascular-risk stratification, minimum laboratory tests, complementary investigations and specialist investigations where clinically indicated.[24][25][26][27]
• Provide lifestyle modification for all patients, including dietary sodium reduction, healthier food preparation, weight control, aerobic activity, smoking cessation, alcohol moderation, stress management and adequate rest; offer structured group education and individual adaptation to patients’ habits and circumstances.[5][28][29][30]
• Initiate and adjust medicines according to hypertension stage, persistence of raised blood pressure, risk factors, organ damage and associated disease; use low initial doses where appropriate, review adherence and tolerance, and add or modify treatment when control remains inadequate.[10][11][31][12]
• Refer patients for integrated support from nursing, nutrition, social work, oral health and mental-health services, and use specialist co-management for complex cases, resistant hypertension, secondary hypertension, crises and high-risk conditions.[32][16][33]
• Apply the Unified Referral and Counter-referral System to ensure continuity between levels of care, document clinical information and investigations, and return patients to the originating facility when appropriate.[16]
• Schedule multidisciplinary follow-up according to year of care, clinical response, complications and professional judgement, including regular medical, nursing, nutrition, dental, mental-health and specialist reviews.[34][3]
• Record detection, assessment, treatment, education, referrals, rehabilitation, laboratory results and professional activities in designated clinical records, activity sheets, case-monitoring cards and Medical Records and Statistics Department submissions.[33][17]
• Monitor implementation through process, outcome and structural indicators, using health-information records and annual reporting. Indicators include diagnosis and programme-enrolment measures, service referrals, repeated blood-pressure checks, educational activity, minimum laboratory testing, and the proportion of patients under control with normal latest blood-pressure readings.[20][35][36]
• Assign local facilities responsibility for applying standards and assessing compliance, regional authorities responsibility for facilitation, supervision and evaluation, and central authorities responsibility for national organisation, supervision and updating.[19][20]

Monitoring & Evaluation

The guideline establishes a predominantly clinical and service-delivery monitoring system for hypertension, combining routine patient records, scheduled follow-up, measurement quality controls, annual management indicators, and reporting through health-facility information systems. It also assigns monitoring and supervision functions across local, regional and central levels, although several extracts do not specify audit methods, indicator targets or formal accountability procedures.[37][33][38][20]

• Establish health-management indicators to monitor and evaluate compliance with the guideline, including indicators contained in its annexes.[37][2]
• Record blood-pressure readings during every medical consultation, repeat measurements when indicated, and enter results in the patient’s clinical record.[21][22][6]
• Record weight, height, body mass index, waist circumference, tobacco and alcohol assessments, physical-activity counselling, patient and family education, referrals, prescribed treatment and examination findings in clinical records.[24][26][27][32]
• Conduct annual laboratory examinations for people attending health checks in accordance with comprehensive health standards and the relevant age group.[24]
• Use diagnostic assessment to confirm hypertension, classify blood-pressure levels, identify secondary causes and target-organ damage, assess cardiovascular risk, and determine whether further investigation or follow-up is required.[9][23]
• Maintain accurate measurement through functioning equipment, appropriate technique and regular calibration of aneroid and electronic blood-pressure devices against a mercury manometer.[39][23][29]
• Review treatment response after non-pharmacological management and adjust medication according to blood-pressure control, adherence, tolerance, adverse effects, interactions, organ damage and associated risk.[10][11][31][12][13]
• Schedule multidisciplinary follow-up during the first year, including at least six medical and nursing reviews, three nutrition reviews and two dental reviews, with adjusted minimum schedules in subsequent years.[34]
• Provide annual minimum inputs of six nursing controls, three nutrition controls, two dental controls, two social-work controls, one mental-health consultation and one specialist consultation.[3]
• Use the Unified Referral and Counter-referral System to document referrals, investigations, treatment and return to the originating facility, supporting continuity across levels of care.[16]
• Submit daily professional activity records and designated programme forms to the Medical Records and Statistics Department; record nursing care in progress sheets and appointments and home visits on case-monitoring cards.[33][17]
• Monitor group lifestyle interventions through food-intake review, weekly goals, weight, waist circumference and blood pressure, while evaluating changes in physical activity, motivation and sustained behaviour.[29][30][40]
• Track annually the proportions of new diagnoses, total diagnosed patients, pregnant women diagnosed with hypertension and hypertensive patients enrolled in the Adult Health Programme.[20]
• Calculate process indicators as the number of hypertensive patients receiving a specified service or activity divided by the relevant total number of hypertensive patients attended during the evaluation period, multiplied by 100; report these indicators annually.[35][36]
• Monitor outcome indicators including the proportion of patients under control whose latest blood-pressure reading is normal and the proportion of controlled patients with diabetes mellitus.[36]
• Assign local facilities to apply standards and assess compliance, regional authorities to facilitate implementation, supervision and evaluation, and the central level to develop, organise, supervise, evaluate and update standards nationally.[19][20]
• Document the commitments and achievements of guideline drafting or updating commissions through minutes or another verification mechanism, and update and publish the guideline every five years.[17][18]

The extracts identify records, activity sheets, case-monitoring cards, laboratory-result records, clinical-variable records and patient-activity records as data sources. They do not consistently specify indicator targets, full indicator formulae, audit procedures, evaluation timelines, surveillance targets or external accountability mechanisms.[33][20][35][36]

Costing & Financing

Costing information is limited. Initial development of the guideline occurred without external financing, while implementation is expected to optimise existing resources in regional services and health facilities.[37]

• Optimise existing resources through efficient appointment control, resource management and use of efficient medicines when initiating treatment.[37]
• Consider the economic resources of both the patient and health institution, alongside clinical importance and disease course, when selecting and recording investigations.[27]
• Select the least costly treatment where efficacy and safety are equivalent.[13]
• Adapt community and facility prevention activities to resources available in health facilities and communities.[4]
• Identify resources in action plans for updating the guideline, alongside objectives, responsibilities, timing and methodology.[17]
• Recognise that non-communicable diseases impose significant costs on health systems.[41]

No quantified programme budget, expenditure estimate, medicine price, tariff, financial allocation, funding gap, financing mechanism, resource-mobilisation target or economic assumption is specified in the supplied material.[37][3][17]